These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17063696)

  • 1. Tolerability and efficacy of benazepril in cats with chronic kidney disease.
    King JN; Gunn-Moore DA; Tasker S; Gleadhill A; Strehlau G;
    J Vet Intern Med; 2006; 20(5):1054-64. PubMed ID: 17063696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats.
    Mizutani H; Koyama H; Watanabe T; Kitagawa H; Nakano M; Kajiwara K; King JN
    J Vet Intern Med; 2006; 20(5):1074-9. PubMed ID: 17063698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in cats with chronic kidney disease.
    King JN; Tasker S; Gunn-Moore DA; Strehlau G;
    J Vet Intern Med; 2007; 21(5):906-16. PubMed ID: 17939542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Benazepril on Survival of Dogs with Chronic Kidney Disease: A Multicenter, Randomized, Blinded, Placebo-Controlled Clinical Trial.
    King JN; Font A; Rousselot JF; Ash RA; Bonfanti U; Brovida C; Crowe ID; Lanore D; Pechereau D; Seewald W; Strehlau G
    J Vet Intern Med; 2017 Jul; 31(4):1113-1122. PubMed ID: 28669137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Chinese rhubarb, Rheum officinale, with and without benazepril on the progression of naturally occurring chronic kidney disease in cats.
    Hanzlicek AS; Roof CJ; Sanderson MW; Grauer GF
    J Vet Intern Med; 2014; 28(4):1221-8. PubMed ID: 24773179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria in chronic kidney disease in cats--prognostic marker or therapeutic target?
    Elliott J; Syme HM
    J Vet Intern Med; 2006; 20(5):1052-3. PubMed ID: 17063695
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease.
    Sent U; Gössl R; Elliott J; Syme HM; Zimmering T
    J Vet Intern Med; 2015; 29(6):1479-87. PubMed ID: 26474314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effects of a therapeutic renal diet to control proteinuria in proteinuric non-azotemic dogs treated with benazepril.
    Cortadellas O; Talavera J; Fernández del Palacio MJ
    J Vet Intern Med; 2014; 28(1):30-7. PubMed ID: 24372810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L?].
    Zhang GH; Hou FF; Zhang X; Liu QF
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):592-6. PubMed ID: 16194413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of benazepril for advanced chronic renal insufficiency.
    Hou FF; Zhang X; Zhang GH; Xie D; Chen PY; Zhang WR; Jiang JP; Liang M; Wang GB; Liu ZR; Geng RW
    N Engl J Med; 2006 Jan; 354(2):131-40. PubMed ID: 16407508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo-controlled clinical trial.
    King JN; Martin M; Chetboul V; Ferasin L; French AT; Strehlau G; Seewald W; Smith SGW; Swift ST; Roberts SL; Harvey AM; Little CJL; Caney SMA; Simpson KE; Sparkes AH; Mardell EJ; Bomassi E; Muller C; Sauvage JP; Diquélou A; Schneider MA; Brown LJ; Clarke DD; Rousselot JF
    J Vet Intern Med; 2019 Nov; 33(6):2559-2571. PubMed ID: 31560137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled clinical trial of the use of benazepril and heparin for the treatment of chronic kidney disease in dogs.
    Tenhündfeld J; Wefstaedt P; Nolte IJ
    J Am Vet Med Assoc; 2009 Apr; 234(8):1031-7. PubMed ID: 19366333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure.
    Watanabe T; Mishina M
    J Vet Med Sci; 2007 Oct; 69(10):1015-23. PubMed ID: 17984588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
    Maschio G; Alberti D; Janin G; Locatelli F; Mann JF; Motolese M; Ponticelli C; Ritz E; Zucchelli P
    N Engl J Med; 1996 Apr; 334(15):939-45. PubMed ID: 8596594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency.
    Brown SA; Brown CA; Jacobs G; Stiles J; Hendi RS; Wilson S
    Am J Vet Res; 2001 Mar; 62(3):375-83. PubMed ID: 11277203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of renal insufficiency on the pharmacokinetics and pharmacodynamics of benazepril in cats.
    King JN; Strehlau G; Wernsing J; Brown SA
    J Vet Pharmacol Ther; 2002 Oct; 25(5):371-8. PubMed ID: 12423228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of urine albumin/creatinine ratio for estimation of proteinuria in cats and dogs.
    Kuwahar Y; Nishii N; Takasu M; Ohba Y; Maeda S; Kitagawa H
    J Vet Med Sci; 2008 Aug; 70(8):865-7. PubMed ID: 18772568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial. The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group.
    Maschio G; Alberti D; Locatelli F; Mann JF; Motolese M; Ponticelli C; Ritz E; Janin G; Zucchelli P
    J Cardiovasc Pharmacol; 1999; 33 Suppl 1():S16-20; discussion S41-3. PubMed ID: 10028949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.